ycopene and flow mediated dilatation index and blood pressure
Phase 2
- Conditions
- Heart failure.Heart failure
- Registration Number
- IRCT20210614051574N4
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
The person's desire to participate in the project
Heart failure due to myocardial infarction with a ejection fraction below 40%
Having a body mass index between 18.5 to 30
Exclusion Criteria
Suffering from autoimmune, respiratory, acute phase of cancer or surgery, infectious and liver diseases and diabetes
Having other heart diseases
Taking corticosteroid and immunosuppressive drugs
Consumption of supplements with antioxidant properties
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Flow mediated dilatation index. Timepoint: Before and 8 weeks after interventions. Method of measurement: Ultrasound.;Blood pressure. Timepoint: Before and 8 weeks after interventions. Method of measurement: Blood pressure monitor.
- Secondary Outcome Measures
Name Time Method